Stock comparison

BIIBvsNTRA

Biogen IncvsNatera Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

BIIB

Biogen Inc

$187.88

+6.91%

Biotechnology$25.8BNASDAQ
NTRA

Natera Inc

$201.14

-11.94%

Biotechnology$28.0BNASDAQ

60-day price, rebased to 100

BIIB +6.64% · NTRA -13.11%

Round-by-round

BIIB 3·NTRA 2· 1tie
EdgeBIIB

Valuation upside

+7.40% vs -67.20% to DCF fair value

EdgeNTRA

Balance-sheet strength

Altman Z 3.10 vs 23.91

EdgeBIIB

Fundamental quality

Piotroski 6.00 vs 5.00 (of 9)

EdgeNTRA

Growth + margins

Rule-of-40 23.00 vs 39.20

EdgeBIIB

60-day momentum

+6.64% vs -13.11% price return

Tie

Market-cap liquidity

$25.8B vs $28.0B

Verdict

Across6categories,BIIBtakes the edge with3wins to2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onBIIBorNTRA

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.

For informational and educational purposes only. Not financial advice. Learn more